Global Acute Viral Rhinosinusitis Treatment Market to Reach US$3.88 Billion by 2030, Driven by High Prevalence and Demand for Symptomatic Relief
various subtypes such as acute, subacute, recurrent acute, and chronic rhinosinusitis. Acute rhinosinusitis can be of bacterial or viral origin, with most cases resulting from …